Larissa J Mooney1, Christopher Cooper2, Edythe D London3, Joy Chudzynski4, Brett Dolezal5, Daniel Dickerson6, Mary-Lynn Brecht7, Jose Peñate8, Richard A Rawson9. 1. Integrated Substance Abuse Programs, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, 11075 Santa Monica Blvd., Los Angeles, CA 90025, United States. Electronic address: lmooney@mednet.ucla.edu. 2. Exercise Physiology Research Laboratory, Division of Pulmonary Medicine, David Geffen School of Medicine, 10833 Le Conte 37-131 CHS, University of California, Los Angeles, Los Angeles, CA 90095, United States. Electronic address: ccooper@mednet.ucla.edu. 3. Semel Institute, David Geffen School of Medicine, University of California, 760 Westwood Plaza, Room C8-831, Los Angeles, CA 90024, United States. Electronic address: ELondon@mednet.ucla.edu. 4. Integrated Substance Abuse Programs, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, 11075 Santa Monica Blvd., Los Angeles, CA 90025, United States. Electronic address: joychud@ucla.edu. 5. Exercise Physiology Research Laboratory, Division of Pulmonary Medicine, David Geffen School of Medicine, 10833 Le Conte 37-131 CHS, University of California, Los Angeles, Los Angeles, CA 90095, United States. Electronic address: BDolezal@mednet.ucla.edu. 6. Integrated Substance Abuse Programs, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, 11075 Santa Monica Blvd., Los Angeles, CA 90025, United States. Electronic address: Daniel.dickerson@ucla.edu. 7. Integrated Substance Abuse Programs, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, 11075 Santa Monica Blvd., Los Angeles, CA 90025, United States. Electronic address: LBrecht@mednet.ucla.edu. 8. Integrated Substance Abuse Programs, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, 11075 Santa Monica Blvd., Los Angeles, CA 90025, United States. Electronic address: jpenate@ucla.edu. 9. Integrated Substance Abuse Programs, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, 11075 Santa Monica Blvd., Los Angeles, CA 90025, United States. Electronic address: rrawson@mednet.ucla.edu.
Abstract
BACKGROUND: Effective pharmacotherapies to treat methamphetamine (MA) dependence have not been identified, and behavioral therapies are marginally effective. Based on behavioral studies demonstrating the potential efficacy of aerobic exercise for improving depressive symptoms, anxiety, cognitive deficits, and substance use outcomes, the study described here is examining exercise as a potential treatment for MA-dependent individuals. METHODS: This study is randomizing 150 participants with MA dependence at a residential treatment facility for addictive disorders to receive either athrice-weekly structured aerobic and resistance exercise intervention or a health education condition. Recruitment commenced in March, 2010. Enrollment and follow-up phases are ongoing, and recruitment is exceeding targeted enrollment rates. CONCLUSIONS: Seeking evidence for a possibly effective adjunct to traditional behavioral approaches for treatment of MA dependence, this study is assessing the ability of an 8-week aerobic and resistance exercise protocol to reduce relapse to MA use during a 12-week follow-up period after discharge from residential-based treatment. The study also is evaluating improvements in health and functional outcomes during and after the protocol. This paper describes the design and methods of the study.
RCT Entities:
BACKGROUND: Effective pharmacotherapies to treat methamphetamine (MA) dependence have not been identified, and behavioral therapies are marginally effective. Based on behavioral studies demonstrating the potential efficacy of aerobic exercise for improving depressive symptoms, anxiety, cognitive deficits, and substance use outcomes, the study described here is examining exercise as a potential treatment for MA-dependent individuals. METHODS: This study is randomizing 150 participants with MA dependence at a residential treatment facility for addictive disorders to receive either a thrice-weekly structured aerobic and resistance exercise intervention or a health education condition. Recruitment commenced in March, 2010. Enrollment and follow-up phases are ongoing, and recruitment is exceeding targeted enrollment rates. CONCLUSIONS: Seeking evidence for a possibly effective adjunct to traditional behavioral approaches for treatment of MA dependence, this study is assessing the ability of an 8-week aerobic and resistance exercise protocol to reduce relapse to MA use during a 12-week follow-up period after discharge from residential-based treatment. The study also is evaluating improvements in health and functional outcomes during and after the protocol. This paper describes the design and methods of the study.
Authors: Susan R Tate; Johnny Wu; John R McQuaid; Kevin Cummins; Chris Shriver; Marketa Krenek; Sandra A Brown Journal: Psychol Addict Behav Date: 2008-03
Authors: N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan Journal: J Neurosci Date: 2001-12-01 Impact factor: 6.167
Authors: Brett A Dolezal; Joy Chudzynski; Thomas W Storer; Marlon Abrazado; Jose Penate; Larissa Mooney; Daniel Dickerson; Richard A Rawson; Christopher B Cooper Journal: J Addict Med Date: 2013 Mar-Apr Impact factor: 3.702
Authors: Andreas Ströhle; Meline Stoy; Barbara Graetz; Michael Scheel; André Wittmann; Jürgen Gallinat; Undine E Lang; Fernando Dimeo; Rainer Hellweg Journal: Psychoneuroendocrinology Date: 2009-08-13 Impact factor: 4.905
Authors: Brett Andrew Dolezal; Joy Chudzynski; Daniel Dickerson; Larissa Mooney; Richard A Rawson; Alan Garfinkel; Christopher B Cooper Journal: Med Sci Sports Exerc Date: 2014-06 Impact factor: 5.411
Authors: Richard A Rawson; Joy Chudzynski; Larissa Mooney; Rachel Gonzales; Alfonso Ang; Daniel Dickerson; Jose Penate; Bilal A Salem; Brett Dolezal; Christopher B Cooper Journal: Drug Alcohol Depend Date: 2015-09-03 Impact factor: 4.492
Authors: Richard A Rawson; Joy Chudzynski; Rachel Gonzales; Larissa Mooney; Daniel Dickerson; Alfonso Ang; Brett Dolezal; Christopher B Cooper Journal: J Subst Abuse Treat Date: 2015-04-15
Authors: Claire E Blevins; Ana M Abrantes; Megan E Kurth; Alan L Gordon; Michael D Stein Journal: Arch Psychiatr Nurs Date: 2018-02-02 Impact factor: 2.218
Authors: Chelsea L Robertson; Kenji Ishibashi; Joy Chudzynski; Larissa J Mooney; Richard A Rawson; Brett A Dolezal; Christopher B Cooper; Amira K Brown; Mark A Mandelkern; Edythe D London Journal: Neuropsychopharmacology Date: 2015-10-27 Impact factor: 7.853
Authors: Yang Yan-Guang; Chen Jing-Yi; Pang Xiao-Wu; Shen Meng-Lu; Yang Su-Yong; Xu Ding; Xiao Ke; Wang Tian-Yuan; Wang Jia-Bin; Zhu Dong Journal: BMC Sports Sci Med Rehabil Date: 2021-01-21
Authors: Jue Yang; Jun Tan; Lan Zheng; Chun Xia Lu; Wen Qi Hou; Yi Liu; Qiu Fang Li; Jin Xiu Li; Dan Cheng; Xu Luo; Jun Zhang Journal: Front Mol Neurosci Date: 2020-03-06 Impact factor: 5.639